The current institutional shareholding score of Evaxion Biotech A/S is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 3.88%, representing a quarter-over-quarter increase of 48.82%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.47% of shares outstanding, with 0.06% decrease in holdings.